Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

NASH Leading Cause of HCC in LT Patients

Clin Gastroenterol Hepatol; ePub 2018 Jun 13; Younossi, et al

Non-alcoholic steatohepatitis (NASH) is the most rapidly growing cause of hepatocellular carcinoma (HCC) among US patients listed for liver transplantation (LT), a recent study found. Researchers used the Scientific Registry of Transplant Recipients (2002-2016) to estimate the trends in prevalence of HCC in LT candidates with the most common types of chronic liver disease: alcoholic liver disease (ALD), chronic hepatitis B (CHB), chronic hepatitis C (CHC), and NASH. They found:

  • 158,347 adult LT candidates were included in the study (16.5% had HCC; this proportion increased from 6.4% in 2002 to 23.0% in 2016).
  • CHC remained the most common etiology for HCC (65%) over the study period.
  • The proportions of HCC accounted for by CHC and ALD remained stable, the proportion of CHB decreased 3.1-fold, while the proportion of NASH in HCC increased 7.7-fold.
  • Moreover, since 2002, the prevalence of HCC in LT candidates with NASH increased 11.8-fold.

Citation:

Younossi Z, Stepanova M, Ong JP, et al. Non-alcoholic steatohepatitis it the fastest growing cause of hepatocellular carcinoma in liver transplant candidates. [Published online ahead of print June 13, 2018]. Clin Gastroenterol Hepatol. doi:10.1016/j.cgh.2018.05.057.

This Week's Must Reads

Opioid Prescribing in Veterans with Cirrhosis, Clin Gastroenterol Hepatol; ePub 2018 Oct 17; Rogal, et al

Efficacy of HZV in Patients with IBD, Clin Gastroenterol Hepatol; ePub 2018 Oct 13; Khan, et al

Guideline Adherence for Treatment of Chronic HBV, Clin Gastroenterol Hepatol; ePub 2018 Oct 13; Nguyen, et al

Burden of Gastrointestinal Diseases in the US, Gastroenterology; ePub 2018 Oct 10; Peery, et al

Family History & Risk of CRC in Patients with IBD, Clin Gastroenterol Hepatol; ePub 2018 Sep 26; Samadder, et al

Must Reads in GI Oncology

Family History & Risk of CRC in Patients with IBD, Clin Gastroenterol Hepatol; ePub 2018 Sep 26; Samadder, et al

Failures in the CRC Screening Process & Risk of Death, Gastroenterology; ePub 2018 Sep 27; Doubeni, et al

FIT for CRC Screening in a Minority Population, J Clin Gastroenterol; ePub 2018 Sep 15; Ramai, et al

Obesity and Diabetes as ICC Risk Factors, Am J Gastroenterol; ePub 2018 Sep 3; Petrick, et al

CRC Tumors & Genetic Testing in Minority Patients , Clin Gastroenterol Hepatol; ePub 2018 Aug 18; Muller, et al